Cáncer » Cáncer Hematológico
Coordinador de Grupo
Juan Carlos García Ruiz
Doctor en Medicina
Jefe de Servicio Hematología - Hemoterapia del HUC
Profesor laboral Unidad Docente Facultad de Medicina y Enfermería de la UPV/EHU, Dpto. Medicina
OSI Eskerraldea Enkarterri Cruces
Miembros del Grupo
Elena Amutio Díez
Saioa Arambarri Uruñuela
Olga Arce Fernández
Beatriz Arrizabalaga Amuchastegui
Javier Arzuaga Méndez
Amaia Balerdi Malcorra
Tomás Carrascosa Vallejo
Roberto Céspedes López
María Cristina de Barrenetxea Lekue
Rafael Andrés del Orbe Barreto
Zuriñe Diez Gallarreta
Ianire Etxeguren Urkixo
Ayman Gaafar Elekary
Eukene Gainza González
Susana Herráez Rodríguez
Fernando Marco de Lucas
José Antonio Márquez Navarro
Xabier Martin Martitegui
Juan José Mateos Mazón
María Dolores Moragues Tosantos
Jesús María Ojanguren Bergaz
María Puente Pomposo
Juan Ignacio Rodríguez Gutiérrez
Líneas de Investigación
Diagnóstico de infecciones fúngicas invasivas.
Tratamiento de hemopatías malignas.
Trasplante de progenitores hematopoyéticos.
Sobrecarga férrica.
Terapia celular.
Actividades del Grupo

El Grupo de Cáncer Hematológico desarrolla su actividad sobre enfermedades hematológicas malignas, fundamentalmente: leucemias agudas, síndromes mielodisplásicos (SMDp) y mieloproliferativos (SMPc), linfomas y mieloma múltiple.

Esta actividad se lleva a cabo en forma de ensayos clínicos con fármacos, en distintas fases de desarrollo, estudios de registro y proyectos de investigación.

Dentro de los ensayos se incluyen el uso de midostaurin en leucemias agudas mieloides, la lenalidomida y el luspatercept en SMDp, el ruxolitinib y nilotinib en SMPc y distintos esquemas de tratamiento en linfomas y mieloma múltiple.

Los estudios de registro atienden al reporte de pacientes trasplantados al EBMT (Grupo Europeo de Trasplante de Progenitores Hematopoyéticos) y al Registro Nacional de Hemoglobinuria Paroxística Nocturna, desde donde se generan habitualmente estudios retrospectivos.

Los proyectos de investigación activos actualmente estudian el papel de las células NK y del ejercicio (EFIKRONIC) en la reconstitución inmune de pacientes sometidos a trasplantes autólogos y su papel en las recaídas.

Además, el grupo de Cáncer Hematológico pertenece al Grupo de Estudio de la Infección Fúngica Invasora de la UPV/EHU para el diagnóstico de este tipo de infección en pacientes hematológicos en situación de alto riesgo de contraerla.

Publicaciones Científicas

Moreno Gamiz M, Mateos Mazon JJ, Posada Alcon L, Gomez Perez C, Arzuaga Mendez J, Martin Martitegui X, Balerdi Malcorra A, Landeta Callejo E, Amutio Diez, ME, García Ruiz JC. Carlosconditioning with bumel in patients subjected to double automotive transplantation in multiple myeloma; experience of a center. Haematologica 2018. MEETING ABSTRACT.

Chen-Liang TH, Hurtado Lopez AM., Palomo L, Bernal Del Castillo T, Tormo M, Lourdes Hermosin M, Jimenez, MJ, Navarro B, Such E, del Orbe Barreto RA. de Haro N, Lopez Cadenas F. Muingermline and Acquired Genetic Variants in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ dysfunction. Blood 2018. MEETING ABSTRACT.

Caamano ML, Gimeno Lozano JJ, Amunarriz Ageda C, Mateoa Mazon JJ, Rifon Roca J, Moreno Chulilla JA, Hermosilla Fernandez M, Gracia Pina JA, Zalba Marcos S, Arroyo Rodriguez JL, Uresandi Iruin A, Vallejo Llamas A. Hematopoyetic implant of a series of patients mobilized with plerixafor. Multicenter retrospective study Haematologica. 2018. MEETING ABSTRACT.

de Lucio Delgado A, Rial Rodríguez JR, González Cruz M, del Orbe Barreto RA, Raya JM. hemolisis in diabetic patient. A case reportrevista. Rev Esp Endocrinol Pediatr 2018; 9(1):56-58

Espinet B Ramos S, Gomez-Llonin A, Bougeon S, Jose Calasanz M, Blanco L, Collado R, Salgado R, Ortega M, Jose Larrayoz M, Batlle A, Campeny A, Valiente A, Abella E. Identification of Complex Karyotypes in Chronic Lymphocytic Leukemia: Comparison of Chromosome Banding Analysis and Genomic Microarray techniques modern. Pathology. 2018. MEETING ABSTRACT.

Espinet B, Ramos S, Gomez-Llonin A, Bougeon S, Jose Calasanz M, Blanco L, Collado R, Salgado R, Ortega M, Larrayoz Mj, Batlle Ana, Campeny A, Valiente A, Abella E, Identification of Complex Karyotypes in Chronic Lymphocytic Leukemia: Comparison of Chromosome Banding Analysis and Genomic Microarray techniques laboratory Investigación. 2018. MEETING ABSTRACT.

Arzuaga Mendez J, Robado Juez N, Leal Martínez I, Insunza Oleaga L, Moreno Gamiz M, del Orbe Barreto RA, García Ruiz JC, Arrizabalaga Amuchastegui B. Idiopathic erythrocytosis, a benign situation? Haematologica. MEETING ABSTRACT.

Enric Ramis-Zaldivar J, Gonzalez-Farre B, Balague O, Celis V, Nadeu A, Martin Guerrero I, Garrido M, Gaafar Eleraky A, Sunol M, Barcena C, Garcia-Bragado F, Andion M. B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult counterparts. Blood. 2018. MEETING ABSTRACT.

Martínez-Cuadrón D, Montesinos P, Vellenga E, Bernal T, Salamero O, Holowiecka A, Brunet S, Gil C, Benavente C, Ribera JM, Pérez-Encinas M, De la Serna J, Esteve J, Rubio V, González-Campos J, Escoda L, Amutio ME, Arnan M, Arias J, Negri S, Lowënberg B, Sanz MA. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy. Leukemia. 2018 Jan;32(1):21-29. FI: 10,023(Q1). DOI: 10.1038/leu.2017.178.

Zaldumbide Dueñas l, Caamano V, Saiz Camin M, Malaxetxebarria S, Velasco Benito V, Solano JD, Gonzalez Vadillo M, Mosteiro Gonzalez l, Gaafar Eleraky A. Malignant ossifying fibromyxoid tumour with multiple recurrences in a child. Virchows. Archiv. 2018. MEETING ABSTRACT.

Velasco Benito V, Diaz Ramon JL, Barrutia Borque A., Esteban Terradillos S., Marcos A., Saiz Camin M, Caamano Villaverde V, Mosteiro Gonzalez L, Gonzalez Vadillo M, Gaafar Eleraky A, Nogueira Gregorio A, Parron Collar D. Multinucleated giant cell angiohistiocitoma, a subtle pattern easy to missvirchows Archiv- 2018. MEETING ABSTRACT.

Aldamiza Echevarria Azuara LJ, Luz Couce M, Villate Bejarano O, Fernández-Marmiesse a, Piñan Frances MA. New CTSA mutation in early infantile galactosialidosis. Pedia. Intern. 2018. MEETING ABSTRACT.

Velasco Benito V, Gónzalez Hermosa MR Pena Merino L, Barrutia Borque A, Andres Alvarez L, Fernandez de Larrinoa A, Mosteriro González L, Saiz Camin M, Caamano Villaverde, Gonzalez Vadillo M, Gaafar A. Papular epidermal nevus with "skyline" basal cell layer (PENS), and PEN syndrome in triplets siblings. Virchows Archiv. 2018. MEETING ABSTRACT.

Lopez Cadenas F, Lumbreras E, Xicoy B, Sanchez-Garcia J, Fenaux P, Coll R, Slama Borhane A Hernandez-Rivas J, Thepot S, Bernal T, Arrizabalaga Amuchastegui B, Guerci, Agnes Sanz G, Barphase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) - Preliminary Blinded Analysis of the European Sintra-REV trial. Blood. 2018. MEETING ABSTRACT.

Andres Alvarez l, Velasco V, Saiz M, Mosteiro-González L, Caamano V, Malaxetxebarria S, González Hermosa MR, Marcos A, Diaz de Lezcano I, Gaafar Eleraky A. Primary diffuse large B-cell lymphoma of the breast: report of 8 cases. Virchows Archiv. 2018. MEETING ABSTRACT.

Ferrer Marin, Francisca, Arroyo, Ana Belen F., Bellosillo, Beatriz, Zamora, Lurdes, Kerguelen Fuentes, Ana, Velez, Patricia, Luno, Elisa, Hernandez Boluda, Juan Carlos, Ayala, Rosa, Viviana Fiallo, Dolly, Garcia Gutierrez, Jose Valentin, Arrizabalaga B. Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 signaling. Blood. 2018. MEETING ABSTRACT.

Arrieta-Aguirre I, Menéndez-Manjón P, Cuétara MS, Fernández de Larrinoa I, García-Ruiz JC, Moragues MD. Sequencing of FKS Hot Spot 1 from Saprochaete capitata To Search for a Relationship to Reduced Echinocandin Susceptibility. Antimicrob Agents Chemother. 2018;62(2). pii: e01246-17. FI: 4,255(Q1). DOI: 10.1128/AAC.01246-17.

Saiz Camin, M., Mosteiro Gonzalez, Lorena, Velasco Benito, Veronica, Malaxetxebarria, S., Caamano, V., Gonzalez Hermosa, Maria Del Rosario Fatima, Gaafar Eleraky, Ayman, Andres Alvarez, Leire, Zaldumbide Dueñas, Laura, Fernandez-Lomana, E., Atienza, M., nsolitary fibrous tumour of the pleura: review of cases in a university hospital over the last twenty years. Virchows Archiv. 2018. MEETING ABSTRACT.

Fenaux, Pierre, Platzbecker, Uwe, Mufti, Ghulam J., Garcia-Manero, Guillermo, Buckstein, Rena, Santini, Valeria, Diez-Campelo, Maria, Finelli, Carlo, Cazzola, Mario, Ilhan, Osman, Sekeres, Mikkael A., Falantes, Jose F., Arrizabalaga Amuchastegui B, The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require red Blood- 2018. MEETING ABSTRACT.

Mingo Gomez De Oteo, Janire, Luna Blanco, Sandra, Gaafar Eleraky, Ayman, Ruiz, R., Carracedo, A., Guerra, I., Lopez Fernandez De Villaverde, Jose Ignacio, Pulido Murillo, Rafael. The relevance of precision epitope mapping for accurate oncologic diagnostic based on PTEN protein expression in tumours. Virchows Archiv. 2018. MEETING ABSTRACT.

Moreno Gamiz, M., Arrizabalaga Amuchastegui, Beatriz, Del Orbe Barreto, Rafael Andres, Gomez Perez, C., Duenas Usategui, M., Mateos Mazon, Juan Jose, Arzuaga Mendez, J., Garcia Ruiz, Juan Carlos. Thrombocitopenic thrombotic purple acquired in the first quarter of pregnancy: a purpose of A case. Haematologica. 2018. MEETING ABSTRACT.

Roy, Noemi, Proven, Melanie, Roberts, Irene, Tamary, Hannah, Swinkels, Dorine W., Patricia, Aguilar-Martinez, Bianchi, Paola, Colombatti, Raffaella, Russo, Roberta, Clark, Barnaby, Sanchez, Mayka, Del Orbe Barreto, Rafael Andres, Fermo, Elisa. Viprakasit Towards an External Quality Assessment for Next Generation Sequencing in the Diagnosis of Rare Inherited anaemias. Blood. 2018. MEETING ABSTRACT.

Alonso Caballero, Clara, Arrizabalaga Amuchastegui, Beatriz, Del Orbe Barreto, Rafael Andres, Leal Martinez, Irene, Caballero Alvarez, D., Uriarte Elguezabal, Jasone, Blanco Gonzalez, Angela, Barrenetxea Lekue, C., Herraez Rodriguez, Susana, Hernandez. Vazutility of ngs in the diagnosis of congenital hemolytic anemias of appearance in the neonatal period- Haematologica. 2018. MEETING ABSTRACT.

Alonso-Dominguez JM, Casado LF, Anguita E, Gomez-Casares MT, Buno I, Ferrer-Marin F, et al. PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase. PLoS One. 2017;12:e0181366. FI:2,806(Q1). DOI:10.1371/journal.pone.0181366.

Arenillas L, Calvo X, Luno E, Senent L, Arnan M, Ramos F, et al. The prognostic evaluation of myelodysplastic syndromes with ring sideroblasts can be improved by considering bone marrow blasts from nonerythroid cells. Leuk. Res. 2017;55:135-6. FI:2,501(Q3). DOI:10.1016/S0145-2126(17)30348-X. ABSTRACT.

Arrieta-Aguirre I, Menendez-Manjon P, Cuetara MS, Lopez-Soria L, Garcia-Ruiz JC, Moragues MD. Molecular identification of saprochaete capitata in human blood and paraffinized tissue samples. J Clin Microbiol. 2017;55:2556-9. FI:3,712(Q2). DOI:10.1128/JCM.00876-17.

Arrieta-Aguirre I, Menendez-Manjon P, de Larrinoa IF, Moragues MD. Experimental evolution of Candida Albicans in the presence of increasing concentrations of fluconazole. Mycoses. 2017;60:73-4. FI:2,252(Q2). ABSTRACT.

Arzuaga J, Mateos J, Lopez-Soria L, Amutio E, Garcia-Ruiz JC. Blood culture number is related to microbiological documentation rate of febrile episodes in patients undergoing autologous stem cell transplantation: single-centre experience in 66 consecutive procedures. Bone Marrow Transplant. 2017;52:242. FI:3,874(Q2). ABSTRACT.

Baptista MJ, Granada I, Morgades M, Calasanz MJ, Canals J, De Castro DR, et al. Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance. Am J Hematol. 2017;92:132-5. FI:5,275(Q1). DOI:10.1002/ajh.24754.

Blanco-Vidal MJ, Duenas-Usategui M, Balerdi-Malcorra A, Puente-Pomposo M, Garcia-Ruiz JC, Montejo-Baranda JM. Piomyositis due to Escherichia coli in haematological patients, an increasing pathology. Rev Esp Quimioter. 2017;30:231-3. FI:0,750(Q4).

Cadenas FL, Xicoy B, Bargay J, Sanz G, Amigo ML, Arrizabalaga B, et al. Preliminary analysis of efficacy and safety of Sintra-Rev Clinical Trial: lenalidomide vs placebo phase 3 study in low/int-1 MDS patients with DEL(5Q) and transfusion independency. Haematologica. 2017;102:484-5. FI:7,702(Q1). ABSTRACT

Cadenas FL, Xicoy B, Sanchez J, Fenaux P, Rivas JAH, Amigo ML, et al. Sintra-rev clinical trial: preliminary analysis of efficacy and safety at week 12 of treatment in MDS del(5Q) and transfusion independence. Leuk Res. 2017;55:52. FI:2,501(Q3). ABSTRACT.

Calvo X, Arenillas L, Luno E, Senent L, Arnan M, Ramos F, et al. Calculating IPSS-R by enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in mds with erythroid predominance. Leuk Res. 2017;55:137-8. FI:2,501(Q3). DOI: 10.1016/S0145-2126(17)30351-X. ABSTRACT.

Calvo X, Arenillas L, Luno E, Senent L, Arnan M, Ramos F, et al. Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised; International Prognostic Scoring System (IPSS-R). Am J Hematol. 2017;92:614-21. FI:5,275(Q1). DOI:10.1002/ajh.24732.

Carrano G, Arrieta I, Sevilla MJ, Moragues MD. Identification of Candida albicans antigens reacting with anti-germ tube antibodies from a rabbit model of Invasive Candidiasis. Phage display approach. Mycoses. 2017;60:195-6. FI:2,252(Q2). ABSTRACT.

Colado E, Arias MM, Valls AG, Rubio ML, Amuchastegui BA, Rubira EL, et al. Clinical impact of age and comorbidity in PNH patients. Haematologica. 2017;102:706. FI:7,702(Q1). ABSTRACT.

Costa D, Nomdedeu M, Pereira A, Calvo X, Colomer J, Soler F, et al. Clinical and biological significance of Y chromosome loss in a series of 2,423 male patients with MDS and CMML. Leuk Res. 2017;55:122-3. FI:2,501(Q3). DOI:10.1016/S0145-2126(17)30321-1. ABSTRACT.

De la Iglesia S, McDonell CN, Valls AG, Romero MTC, Roncero MIG, Amunchastegui BA, et al; GDE SEHH. Surgical management of patients with paroxysmal nocturnal hemoglobinuria; (PNH) - Data from the Spanish PNH registry. Haematologica. 2017;102:403-4. FI:7,702(Q1). ABSTRACT.

De la Iglesia S, Morado M, Arrizabalaga B, Gonzalez A, Beneitez D, Rubio ML, et al. Paroxysmal nocturnal hemoglobinuria and aplastic anaemia-data from the Spanish PNH registry. Haematologica. 2017;102:705. FI:7,702(Q1). ABSTRACT.

Diez A, Carrano G, Cuetara MS, Garcia-Ruiz JC, de Larrinoa IF, Moragues MD. Biomarkers for the diagnosis of Invasive Candidiasis. Mycoses. 2017;60:118-9. FI:2,252(Q2). ABSTRACT.

García-Noblejas A, Cannata-Ortiz J, Conde E, González Barca E, Gutiérrez N, Rojas R, et al. Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO). Ann Hematol. 2017;96:1323-30. FI:3,083(Q2). DOI:10.1007/s00277-017-2998-6.

Irigoyen M, Garcia-Ruiz JC, Berra E. The hypoxia signalling pathway in haematological malignancies. Oncotarget. 2017;8:36832-44. FI:5,168(Q1). DOI:10.18632/oncotarget.15981.

Ivars D, Orero MT, Javier K, Diaz-Vico L, Garcia-Gimenez JL, Mena S, et al. Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload. Clin Biochem. 2017;50:911-7. FI:2,434(Q2). DOI:10.1016/j.clinbiochem.2017.05.018.

Loo SK, Ch'ng ES, Lawrie CH, Muruzabal MA, Gaafar A, Pomposo MP, et al. DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas. Pathology. 2017;49:731-9. FI:2,709(Q2). DOI:10.1016/j.pathol.2017.08.009.

Mazon JJM, Diez MEA, Iruin AU, Malcorra AB, Verde FIZ, Ruiz JCG. When is the best moment and which is the best conditioning regimen to use for the second autologous transplantation in multiple myeloma patients?. Bone Marrow Transplant. 2017;52:474-5. FI:3,874(Q2). ABSTRACT.

Moragues Tosantos MD. Diagnóstico de la candidiasis invasiva mediante biomarcadores hyphal wall protein-1 y metionina sintasa. Rev Iberoam Micol. 2017;34:7-19. FI:1,330(Q3). ABSTRACT.

Nomdedeu M, Pereira A, Calvo X, Colomer J, Sole F, Arias A, et al. Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group. Leuk Res. 2017;63:85-9. FI:2,501(Q3). DOI:10.1016/j.leukres.2017.10.011.

Perez CG, Malcorra AB, Alcon LP, Callejo EL, Martitegui XM, Diez EA, et al. Association between grade of response and outcomes in transplant-eligible myeloma patients. Bone Marrow Transplant. 2017;52:458. FI:3,874(Q2). ABSTRACT.

Puiggros A, Collado R, Calasanz MJ, Ortega M, Ruiz-Xiville N, Rivas-Delgado A, et al. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions. Oncotarget. 2017;8:54297-303. FI:5,168(Q1). DOI:10.18632/oncotarget.17350.

Puiggros A, Gomez-Llonin A, Ramos S, Calasanz MJ, Blanco L, Collado R, et al. Comparison of chromosome banding analysis and genomic microarray techniques for the detection of complex karyotypes in chronic lymphocytic leukemia. Haematologica. 2017;102:422. FI:7,702(Q1). ABSTRACT.

Ropero P, Erquiaga S, Arrizabalaga B, Perez G, de la Iglesia S, Torrejon MJ, et al. Phenotype of mutations in the promoter region of the beta-globin gene. J Clin Pathol. 2017;70:874-8. FI:2,687(Q2). DOI:10.1136/jclinpath-2017-204378.

Senent L, Lorenzo I, Vicente A, Alonso E, Sanzo C, Ramos F, et al. Prognostic implication of the percentage of erythroid cells in bone marrowat diagnosis in patients with myelodysplastic syndrome. Leuk Res. 2017;55:151-52. FI:2,501(Q3). DOI:10.1016/S0145-2126(17)30375-2. ABSTRACT.

Tamayo-Orbegozo E, Amo L, Riñón M, Nieto N, Amutio E, Maruri N, et al. Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells. Oncotarget. 2017;8:99722-39. FI:5,168(Q1). DOI:10.18632/oncotarget.21283.

Villegas A, Núñez R, Gaya A, Cuevas-Ruiz MV, Bosch JM, Carral A, et al. Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry. Ann Hematol. 2017;96: 1727-33. FI:3,083(Q2). DOI:10.1007/s00277-017-3059-x.

Amutio Díez E, Piñán MA, García-Ruiz JC. Hemorragia cerebral en un varón con coagulación intravascular diseminada. Medicine. 2016;12:1315e1-e4.

Arenillas L, Calvo X, Luño E, Senent L, Alonso E, Ramos F, et al. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. J Clin Oncol. 2016;34:3284-92. FI:24,008(Q1). DOI:10.1200/JCO.2016.66.9705.

Balerdi A, Diez H, Iglesias AM, Elicegui ML, Olazabal I, Vara M, et al. Autologous-SCT In Mantle Cell Lymphoma: Role Of Short Induction And Conditioning Regimen In A Series Of Patients With Long Term Follow Up. Bone Marrow Transplant. 2016;51:297. FI:3,874(Q2). ABSTRACT

Blanco G, Puiggros A, Baliakas P, Athanasiadou A, Garcia-Malo MD, Collado R, et al. Chromosome 8 abnormalities are associated with an even worse outcome and karyotype complexity in patients with chronic lymphocytic leukemia and TP53 aberrations. Haematologica. 2016;101: 229-30. FI:7,702(Q1). ABSTRACT

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, et al. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes. Mod Pathol. 2016;29:1541-51. FI:5,728(Q1). DOI:10.1038/modpathol.2016.146.

Colado E, Morado M, Gaya A, Lopez M, Arrizabalaga B, Lavilla E, et al. Importance of age and comorbility in paroxysmal nocturnal haemoglobinuria. Haematologica. 2016;101:262-3. FI:7,702(Q1). ABSTRACT

Costa D, Pereira A, Bernal T, Luno E, Bonanad S, Sanz G, et al. Study of clinical characteristics and prognosis of myelodysplastic syndromes with isolated y chromosome delay. Haematologica. 2016;101: 145. FI:7,702(Q1).

De la Iglesia S, Morado M, Arrizabalaga B, Gonzalez A, Beneitez D, Lopez M, et al. HPN-Aplasia. Experience of the HPN Spanish Registry. Haematologica. 2016;101:263. FI:7,702(Q1). ABSTRACT

Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, Aragües P, Garcia-Ruiz JC, Arrieta A, et al. Severe neonatal jaundice due to a de novo glucose-6-phosphate dehydrogenase deficient mutation. Int J Lab Hematol. 2016;38:e27-9. FI:2,030(Q3). DOI:10.1111/ijlh.12455.

Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, García-Orad Á, Tejada MI, Garcia-Ruiz JC, et al. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing. Int J Lab Hematol. 2016;38:629-38. FI:2,030(Q3). DOI:10.1111/ijlh.12551.

Del Orbe Barreto R, Arrizabalaga B, De la Hoz Rastrollo AB, García-Orad A, Gonzalez Vallejo I, Bento C, et al. Hereditary xerocytosis, a misleading anemia. Ann Hematol. 2016;95:1545-6. FI:3,083(Q2). DOI:10.1007/s00277-016-2716-9.

Del Orbe R, Arrizabalaga B, De la Hoz AB, Martin X, Garcia-Orad A, Molina J, et al. Identification of two new mutations in the gene of the anchirine causes of hereditary spherocytosis. Haematologica. 2016;101:260. FI:7,702(Q1). ABSTRACT

Del Orbe R, Arrizabalaga B, Martin X, Erquiaga S, Garcia-Ruiz JC. Chelation therapy in non-transfusion-dependent iron loading anemia. Experience in a tertiary hospital. Haematologica. 2016;101:852. FI:7,702(Q1). ABSTRACT

Gutierrez I, Morado M, Arrizabalga B, De la Iglesia S, Beneitez D, Valcarce I, et al. Rituximab in automatic hemolitical anemia. Results of the national registry of autoimmune hemolytic anemia. Spanish group of eritropatology. Haematologica. 2016;101:53. FI:7,702(Q1). ABSTRACT

Iruin Irulegui G, Sierra Aisa C, Moretó Quintana A, Martín Martitegui X, García-Ruiz JC. Protocolo de profilaxis de la enfermedad tromboembólica venosa en procesos médicos y quirúrgicos. Medicine. 2016;12:1309-14

Iruin Irulegui G, Sierra Aisa C, Moretó Quintana A, Martín Martitegui X, García-Ruiz JC. Alteraciones del sistema hemostático. Estrategia diagnósticas de la patología hemorrágica. Coagulopatías congénitas. Medicine. 2016;12:1255-66.

Lopez-Cadenas F, Xicoy B, Luno E, Cabrero M, Pedro C, Calabuig M, et al. Clinical and biological factors related to the transfusional dependance in smd diagnosed patients (5Q) and transfusional independence to diagnosis. Haematologica. 2016;101:65-6. FI:7,702(Q1). ABSTRACT

Martin Martitegui X, Iruin Irulegui G, Moretó Quintana A, Sierra Aisa C, Amutio Díez E, García-Ruiz JC. Alteraciones adquiridas de la coagulación. Medicine. 2016;12:1275-83.

Martin X, Arrizabalaga B, Pak Leng A, Ropero P, Erkiaga S, Del Orbe R, et al. Myelodysplastic syndrome with alpha thalassemia acquired by mutation of atrx gene: about a case. Haematologica. 2016;101:150-1. FI:7,702(Q1). ABSTRACT

Martinez-Cuadron D, Montesinos P, Ossenkoppele G, Gonzalez-Huerta AJ, Salamero O, Holowiecka A, et al. Long-term outcome of elderly patients with acute promyelocytic leukemia treated with anthracycline monotherapy and atra-based pethema protocols. Haematologica. 2016;101:178. FI:7,702(Q1). ABSTRACT

Martínez-Feito A, Melero J, Mora-Díaz S, Rodríguez-Vigil C, Elduayen R, González-Granado LI, et al. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation. Immunobiology. 2016;221:40-7. FI:2,720(Q3). DOI:10.1016/j.imbio.2015.08.004.

Moretó Quintana A, Sierra Aisa C, Iruin Irulegui G, Martín Martitegui X, García Ruiz JC. . Protocolo de indicación de la anticoagulación. Medicine. 2016;12:1304-08.

Moretó Quintana A, Sierra Aisa C, Iruin Irulegui G, Martín Martitegui X, García Ruiz JC. Enfermedades de la hemostasia primaria. Púrpuras vasculares. Enfermedades de las plaquetas.Medicine. 2016;12:1267-74.

Pinan MA, Ancin IM, Callejo E, Arrizabalaga B, Moreto A, Sierra C, et al. Assessment of the results of the mutations study in patients with suspected philadelphia negative myeloproliferative syndromes. Haematologica. 2016;101:185. FI:7,702(Q1). ABSTRACT

Posada L, Balerdi A, Gomez C, Martin X, Landeta E, Vara M, et al. Impact of bortezomib's accumulated doses in the survival of patient candidates to autologous transplantation: experience of a centre. Haematologica. 2016;101:99-100. FI:7,702(Q1). ABSTRACT

Puiggros A, Collado R, Calasanz MJ, Ortega M, Ruiz-Xiville N, Rivas-Delgado A, et al. Patients with complex karyotype (CK) lacking TP53 deletions show an equivalent dismal clinical outcome as those with TP53 deletions and non-ck in chronic lymphocytic leukemia. Haematologica. 2016;101:57. FI:7,702(Q1). ABSTRACT

Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, Moragues MD, Antoran A, Pellon A, et al. Candida albicans and cancer: Can this yeast induce cancer development or progression?. Crit Rev Microbiol. 2016;42:181-93. FI:6,281(Q1). DOI:10.3109/1040841X.2014.913004.

Sierra Aisa C, Moretó Quintana A, Iruín Irulegui G, Martín Martitegui X, García Ruiz JC. Protocolo diagnóstico de la trombofilia. Medicine. 2016;12:1299-303.

Sierra Aisa C, Moretó Quintana A, Iruín Irulegui G, Martín Martitegui X, García Ruiz JC. Trombofilia y Trombosis. Medicine. 2016;12:1284-92.

Sierra C, Moretó A, Iruín G, Martín X, García-Ruiz JC. Protocolo diagnóstico y terapéutico de las alteraciones de la hemostasia en el embarazo. Medicine. 2016;12:1293-8.

Vara M, Puente M, Amutio E, Balerdi A, Olazabal I, Díez H, et al. Analysis of risk factors for central nervous system relapse in diffuse large B-cell lymphoma: the experience of a tertiary hospital. Haematologica. 2016;101:704. FI:7,702(Q1). ABSTRACT

Villegas A, Arrizabalaga B, Bonanad S, Colado E, Gaya A, González A, et al; Grupo de Trabajo de HPN de la Sociedad Española de Hematología y Hemoterapia. Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Med Clin (Barc). 2016;146:278.e1-7. FI:1,125(Q3). DOI:10.1016/j.medcli.2015.12.012. ABSTRACT

Albaina O, Sahand IH, Brusca MI, Sullivan DJ, Fernandez de Larrinoa I, Moragues MD. Identification and characterization of nine atypical Candida dubliniensis clinical isolates. J Med Microbiol. 2015;64:147-156. FI:2,269(Q3). DOI:10.1099/jmm.0.078832-0.

Alonso-Dominguez JM, Casado F, Gomez MT, Buno I, Ferrer-Marin F, Anguita E, et al. Measurement of PTCH1 expression at diagnosis is an appropriate tool for tyrosine kinase inhibitors selection in chronic myeloid leukemia patients in chronic phase. Blood. 2015;126. FI:11,841(Q1). ABSTRACT

Ancin I, Landeta E, Amarika I, Maruri N, Olivares N, Rinon M, et al. Babies with acute leukemia of ambigious lineage and T (4;11) (Q21;Q23)/ MLL-AF4 rearrangement. Haematologica. 2015;100:237-238. FI:6,671(Q1). ABSTRACT

Arenillas L, Calvo X, Tormo M, Valcarcel D, Luno E, Alonso E, et al. Considering percentage of blasts on the basis of non-erythroid compartment might improve the classification and prognostication of mds with excess of blast cells. Leukemia Res. 2015; 39:130-131. FI: 2,606(Q3). ABSTRACT

Arenillas L, Calvo X, Tormo M, Valcarcel D, Luno E, Alonso E, et al. Considering the percentage of blasts on the basis of non erythroid cellularity could improve the classification and prognostic evaluation of the myelodysplastic syndrome (SMD) with excess of balsts. Haematologica. 2015;100:135-136. FI:6,671(Q1). ABSTRACT

Arenillas L, Calvo X, Tormo M, Valcarcel D, Luno E, Alonso E, et al. Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts. Blood. 2015;. FI:11,841(Q1). ABSTRACT

Astigarraga I, Garcia-Obregon S, Agirrebengoa K, Balerdi A, Garcia-Ruiz JC, Diaz B, et al. Hemophagocytic lymphohistiocytosis complicating adult patients with hiv infection. Pediatr Blood Cancer. 2015;62:2-0. FI:2,634(Q1). ABSTRACT

Balerdi A, Iglesias A, Olazabal I, Elicegui L, Duenas M, Puente M, et al. Is the autologous stem cell trasplantation in acute myelogenous leukemia a good option? Results of a single institution experience. Bone Marrow Transplant. 2015;50:5607-5608. FI:3,636(Q2). ABSTRACT

Calvo X, Arenillas L, Tormo M, Valcarcel D, Luno E, Alonso E, et al. Erythroleukemia and refractory anemia with excess of blasts of type 1 (AREB-1) with erythroid hyperplasia share clinical- biological characteristics and present a similar prognosis. Haematologica. 2015;100:21-0. FI:6,671(Q1). ABSTRACT

Calvo X, Arenillas L, Tormo M, Valcarcel D, Luno E, Alonso E, et al. RAEB-1 with erythroid hyperplasia and erythroleukemia share clinico-biological features and outcome: a same disease with different labels?. Blood. 2015;126. FI:11,841(Q1). ABSTRACT

Carrano G, Lainz L, Olazabal I, Garcia-Ruiz C, Cuetara MS, Sevilla MJ, et al. Antifungal activity of anti-Candida albicans germ tube antibodies (CAGTA) from patients with Invasive Candidiasis. Mycoses. 2015;58:180-0. FI:2,332(Q2). ABSTRACT

De La Fuente GF, Villegas AM, Nunez R, Gaya A, Cuevas VM, Bosch JM, et al. Acute and chronic renal failure in a cohort of patients in the spanish hpn registry. Haematologica. 2015;100:33-34. FI:6,671(Q1). ABSTRACT

Del Orbe R, Arrizabalaga B, De la Hoz AB, Tejada I, Araguees P, Silva C, et al. The ``next generation sequencing'' utility in the optimization of the diagnosis of the congenital hemoliticas anemia. Haematologica. 2015;100:1-2. FI:6,671(Q1). ABSTRACT

Del Orbe R, Arrizabalaga B, Manco L, Bento C, Ribeiro L, Garcia-Ruiz JC. Severe neonatal jaundice due to a de novo glucose-6-phosphate dehydrogenase deficient class i mutation. Haematologica. 2015;100:587. FI:6,671(Q1). ABSTRACT

Del Orbe R, Arrizabalaga B, Posada L, Moreno MI, Moran MJ. Jak-inhibitors could induce hepcidin downregulation in patients with myelofibrosis. Haematologica. 2015;100:759. FI:6,671(Q1). ABSTRACT

Garcia-Ruiz JC, Olazabal I, Adan RM, Lopez-Soria L, Velasco-Benito V, Sanchez-Aparicio JA, et al. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases. Rev Iberoam Micol. 2015;32:190-196. FI:1,444(Q3). DOI:10.1016/j.riam.2014.11.003.

Gomez C, Mateos JJ, Posada L, Vara M, Diez H, Sierra C, et al. Evolution of graft in patients who benefit from autotransplant of hematopoietic progenitors and who have been mobilized with plerixafor. Haematologica. 2015;100:222-0. FI:6,671(Q1). ABSTRACT

Gutierrez I, Luts I, Lopez M, Morado M, Arrizabalga B, Beneitez D, et al. National record of autoimmune haemolytic anaemia: Preliminary results. Spanish Group of Erythropathology. Haematologica. 2015;100:84-85. FI:6,671(Q1). ABSTRACT

Landeta E, Amarika I, Ancin I, Pian MA, Garcia L, Lopez MA, et al. Acute leukemias of ambigous lineage in a tertiary hospital. Haematologica. 2015;100:255-256. FI:6,671(Q1). ABSTRACT

Nomdedeu M, Galvo X, Costa D, Arnan M, Pomares H, Sanz G, et al. Disease-Attributable Mortality in the Myelodysplastic Syndromes (MDS): A Study from the Spanish MDS Cooperative Group (GESMD). Blood. 2015;126. FI:11,841(Q1). ABSTRACT

Posada L, Guerrero L, Arrizabalaga B, Aragues P, Erkiaga S, Gomez C, et al. Congenital deficit in the metabolism of the cobalamin as a cause of pancytopenia. Haematologica. 2015;100:91-92. FI:6,671(Q1). ABSTRACT

Remacha AF, Arrizabalaga B, Villegas A, Duran MS, Hermosin L, de Paz R, et al. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications. Ann Hematol. 2015;94:779-787. FI:3,022(Q2). DOI:10.1007/s00277-014-2274-y.

Saumell S, Florensa L, Rodriguez-Rivera M, Pedro C, Hernández-Rivas JM, Lumbreras E, et al. Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia. Leukemia Lymphoma. 2015;56:242-243. FI:3,093(Q2). DOI:10.3109/10428194.2014.914197.

Saumell S, Sole F, Arenillas L, Montoro J, Valcarcel D, Pedro C, et al. Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?. PLoS One. 2015;10. FI:3,057(Q1). DOI:10.1371/journal.pone.0129375.

Sierra C, Moreto A, Ancin I, Amarika I, Landeta E, Vara M, et al. Malleolar ulcer by hydroxyurea: the making of an exhaustive history. Haematologica. 2015;100:286-287. FI:6,671(Q1). ABSTRACT

Talarn C, Escoda L, Montesinos P, Amutio E, Pinan MA, Gimenez T, et al. Acute promyelocytic leukemia variant. Incidence and characteristics of the reported cases in the PEHTEMA-LPA case. Haematologica. 2015;100:144-0. FI:6,671(Q1). ABSTRACT

Tapia G, Baptista MJ, Munoz-Marmol AM, Gaafar A, Puente-Pomposo M, Garcia O, et al. MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system. Apmis. 2015;123:596-603. FI:1,933(Q2). DOI:10.1111/apm.12390.

Uresandi A, Vara M, Mateos JJ, Zuazua I, Garcia JC. Result of the determination and direct coombs (CD) in sample of cord of the new born (rN) within the program of prevention of hemolytic disease of the new born (EHRN). Haematologica. 2015;100:231. FI:6,671(Q1). ABSTRACT

Vara M, Diez H, Moreto A, Sierra C, Pinan MA, Iruin G, et al. Techniques of molecular biology applied to Essential Thrombocythemia (ET): determination of the mutations JAK2 V617F and calreticulin. experience of a hospital of tertiary level. Haematologica. 2015;100:282. FI:6,671(Q1). ABSTRACT

Villegas AM, Nunez R, Gaya A, Cuevas MV, Bosch JM, Carral A, et al. Acute and chronic renal failure in a patient cohort from the spanish pnh registry. Haematologica. 2015;100:333-0. FI:6,671(Q1). ABSTRACT

Puiggros A, Venturas M, Salido M, Blanco G, Fernandez-Rodriguez C, Collado R, et al; Grupo Cooperativo Español de Citogenética Hematológica (GCECGH); Grupo Español de Leucemia Linfática Crónica (GELLC).Interstitial 13q14 Deletions Detected in the Karyotype and Translocations with Concomitant Deletion at 13q14 in Chronic Lymphocytic Leukemia: Different Genetic Mechanisms but Equivalent Poorer Clinical Outcome. Gene Chromosomes Cancer. 2014;53:788-97. FI: 4,041(Q1)

Brusca MI, Verdugo F, Amighini C, Albaina O, Moragues MD. Anabolic steroids affect human periodontal health and microbiota. Clin Oral Invest. 2014;18:1579-86. FI: 2,352(Q1)

Sánchez-García J, Del Cañizo C, Lorenzo I, Nomdedeu B, Luño E, de Paz R, et al; Spanish Group on Myelodysplastic Syndromes (GES MD).Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion. Br J Haematol. 2014;166:189-201. FI: 4,711(Q1)

Ardizzoni A, Posteraro B, Baschieri MC, Bugli F, Sáez-Rosòn A, Manca L, et al. An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array. Int J Immunopathol Pharmacol. 2014;27:403-12. FI: 1,617(Q3)

Rojas SM, Díez-Campelo M, Luño E, Cabrero M, Pedro C, Calabuig M, et al. Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis. Leuk Res. 2014;38:304-9. FI: 2,351(Q3)

Sáez-Rosón A, Sevilla MJ, Moragues MD. Identification of superficial Candida albicans germ tube antigens in a rabbit model of disseminated candidiasis. A proteomic approach. Int Microbiol. 2014;17:21-9. FI: 1,326(Q3)

Piñán MA, Ardanaz MT, Guinea JM, García-Ruiz JC. Myeloid sarcoma preceding an acute promyelocytic leukaemia with neuromeningeal infiltration. Ann Hematol. 2014;93:339-40. FI: 2,634(Q2)

Garcia-Noblejas A, Conde E, Martin A, Vidal MJ, Rojas R, Grande C, et al. Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011). Blood. 2014;21:- . FI: 10,452(Q1)

Pombar-Gomez M, Echebarria A, Bilbao-Aldaiturriaga N, Pinan MA, Uriz J, Garcia-Miguel P, et al. Genetic variants in vincristine transporters as neurotoxicity markers in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61:172. FI: 2,386(Q1)

Del Orbe R, Pinan A, Zamora M, Landeta E, Amarika I, Amutio E, et al. BCR-ABL1 ratio log reduction is a better predictor of major molecular response (MMR) than 10% ratio cut-off at 3 months in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Haematologica. 2014;99:78. FI: 5,814(Q1)

Garcia-Gutierrez V, Maestro B, Cervantes F, Lopez Lorenzo JL, Martin Mateos ML, Alvarez A, et al. Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib. Haematologica. 2014;99:337-8. FI: 5,814(Q1)

Amutio E, Del Orbe RA, Amarika I, Landeta E, Zamora ME, Puente M, et al. Tailored therapy for advanced-stage hodgkin lymphoma, guided by interim 18FDG-PET, with beacopp-escalated followed by ABVD regimen decreases refractory disease rates. Haematologica. 2014;99:676-7. FI: 5,814(Q1)

Mateos Mazon JJ, Vara Pampliega M, Uresandi A, Parra I, Landeta E, Zuazua Verde FI, et al. Below what number of CD34+/UL cells on the 4th day of mobilization, in mm patients mobilizated with G-CSF alone, we expect a fail of hematopoietic stem cell collection. Bone Marrow Transplant. 2014;49:527-8. FI: 3,570(Q2)

Moragues MD, Rementeria A, Sevilla MJ, Eraso E, Quindos G. Candida antigens and immune responses: implications for a vaccine. Expert Rev Vaccines. 2014;13:1001-12. FI: 4,210(Q1)

Garcia-Vazquez MD, Morales MC, Mateos-Mazon JJ, Ayestaran J, Fernandez-Conti P, Gomez-Coloma A, et al. Pathology of donor, harvest site and culture medium could determinate mesenchymal stem cell properties. Hum Gene Ther. 2013;24:101. FI: 4,019(Q1). ( Meeting Abstract)

Brusca MI, Verdugo F, Amighini C, Albaina O, Moragues MD. Anabolic steroids affect human periodontal health and microbiota.Clin Oral Investig. 2013 Nov 13.[Epub ahead of print]. FI: FI: 2,200(Q1)

García-Ruiz JC, López-Soria L, Olazábal I, Amutio E, Arrieta-Aguirre I, Velasco-Benito V, et al. Invasive infections caused by Saprochaetecapitata in patients with haematological malignancies: Report of five cases and review of the antifungal therapy. Rev IberoamMicol. 2013;30:248-55. FI: 1,312(Q3)

Arrieta-Aguirre I, Garcia-Ruiz JC, Lopez-Soria L, Olazabal I, Amutio E, Velasco-Benito V, et al. Molecular identification of Magnusiomycescapitatus from paraffinized tissue samples.Mycoses. 2013;56: 81-2. FI: 2,247(Q2). ( Meeting Abstract)

Saez Roson A, Ardizzoni A, Baschieri MC, Bugli F, Sterbini F,  Paroni Orsi CF, et al. Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis. Mycoses.2013;56:78-9. FI: 1,278(Q3). ( Meeting Abstract)

Gutierrez-Camino A, Lopez-Lopez E, Martin-Guerrero I, Garcia-Miguel P, Sanchez-Toledo J, Carbone Baneres A, et al. New susceptibilitymarkers of childhoodacutelymphoblasticleukemia: microrna-relatedpolymorphisms. Ped Blood Cancer. 2013;60:58-9. FI: 2,353(Q1). ( Meeting Abstract).

Amutio E, Olivares M, Arambarri S, del Orbe R, Zamora M, Puente M, et al. Autologous stem cell transplantation in young and fit patients with diffuse large B-cell lymphomas. When to do it?.Bone Marrow Transpl. 2013;48:434-5. FI: 3,541(Q2). ( Meeting Abstract).

Mateos-Mazon JJ, Zamora M, Del Orbe R, Etxeguren I, Olivares M, Uresandi A, et al. Is bortezomib harmful to haemopoietic stem cells in patients with multiple myeloma? Effects on the mobilization of haemopoietic stem cells in patients treated with bortezomib versus non-bortezomib-based induction regimens in multiple myeloma. Bone Marrow Transpl. 2013;48:193. FI: 3,541(Q2). ( Meeting Abstract).

Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L, Aguirre-Urizar JM, Moragues MD, Rautemaa R. Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders . J Oral Pathol Med. 2013;42:243-9. FI: 2,055(Q1)

Lopez-Lopez E, Ballesteros J, Piñan MA, Sanchez de Toledo J, Garcia de Andoin N, Garcia-Miguel P, et al. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenet Genomics. 2013;23:53-61. FI: 3,608(Q1)

Tesis

Autor/a: Rafael Andrés Del Orbe Barreto. Título: Implementación de la Next Generation Sequencing en el diagnóstico de las Anemias Hemolíticas Congénitas. Director/a: Dra. Beatriz Arrizabalaga Amuchastegui, Dra. África García-Orad Carles. UPV/EHU

Autor/a: Aranzazu Sáez Rosón. Título: Caracterización de los anticuerpos anti-micelio de Candida albicans y biomarcadores para el diagnóstico de la candidiasis invasora. Director/a: Dra. María Dolores Moragues Tosantos. UPV/EHU